Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease susceptibility. To describe the human methylome in pancreatic islets and determine the epigenetic basis of T2D, we analyzed DNA methylation of 479,927 CpG sites and the transcriptome in pancreatic islets from T2D and non-diabetic donors. We provide a detailed map of the global DNA methylation pattern in human islets, β- and α-cells. Genomic regions close to the transcription start site showed low degrees of methylation and regions further away from the transcription start site such as the gene body, 3'UTR and intergenic regions showed a higher degree of methylation. While CpG islands were hypomethylated, the surrounding 2 kb shores showed an intermediate degree of methylation, whereas regions further away (shelves and open sea) were hypermethylated in human islets, β- and α-cells. We identified 1,649 CpG sites and 853 genes, including TCF7L2, FTO and KCNQ1, with differential DNA methylation in T2D islets after correction for multiple testing. The majority of the differentially methylated CpG sites had an intermediate degree of methylation and were underrepresented in CpG islands (∼ 7%) and overrepresented in the open sea (∼ 60%). 102 of the differentially methylated genes, including CDKN1A, PDE7B, SEPT9 and EXOC3L2, were differentially expressed in T2D islets. Methylation of CDKN1A and PDE7B promoters in vitro suppressed their transcriptional activity. Functional analyses demonstrated that identified candidate genes affect pancreatic β- and α-cells as Exoc3l silencing reduced exocytosis and overexpression of Cdkn1a, Pde7b and Sept9 perturbed insulin and glucagon secretion in clonal β- and α-cells, respectively. Together, our data can serve as a reference methylome in human islets. We provide new target genes with altered DNA methylation and expression in human T2D islets that contribute to perturbed insulin and glucagon secretion. These results highlight the importance of epigenetics in the pathogenesis of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The human methylome in pancreatic islets from 15 T2D and 34 non-diabetic donors. (A) All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. TSS: proximal promoter, defined as 200 bp or 1500 bp upstream of the transcription start site. UTR: untranslated region. CpG island: 200 bp (or more) stretch of DNA with a C+G content of >50% and an observed CpG/expected CpG in excess of 0.6. Shore: the flanking region of CpG islands, 0–2000 bp. Shelf: regions flanking island shores, i.e., covering 2000–4000 bp distant from the CpG island [68]. Global DNA methylation in human pancreatic islets of T2D and non-diabetic donors is shown for (B) each gene region and (C) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. (D) The absolute difference in DNA methylation of 3,116 individual sites, including 2,988 sites with decreased and 128 sites with increased DNA methylation in T2D compared with non-diabetic human islets with q<0.05 based on a FDR analysis. 1,649 sites with an absolute difference in DNA methylation ≥5% are represented by grey bars. (E) Pie chart describing the number of sites that exhibit increased or decreased DNA methylation in T2D compared with non-diabetic human islets with an absolute difference in methylation ≥5% and q<0.05. The degree of DNA methylation is shown for (F) the 1,596 CpG sites with decreased DNA methylation and (G) the 53 sites with increased DNA methylation in T2D vs. non-diabetic islets in comparison to the degree of methylation of all analyzed CpG sites in the human islets using the Infinium HumanMethylation450 BeadChip.](https://figures.cochat.ai/paper-figures/fd8c276c0dc0486e83f24fd1674f0479/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-1.jpg)



![Figure 5 The human methylome in FACS sorted human β- and α-cell fractions. All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. Global DNA methylation in whole human islets (n = 4) and purified human β- (n = 3) and α-cell (n = 2) fractions is shown for (A) each gene region and (B) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. Data are mean ± SEM.](https://figures.cochat.ai/paper-figures/4b940823eaa34b94a0a86ee0b9008d18/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 2×
“We next exported the DNA methylation data from GenomeStudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“Next a quantile normalization was performed as described [85].”
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 2×
“methylation paradox which still remains unexplained [46].”
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · cited 1×
“It has previously been established that DNA methylation in differentiated mammalian cells mainly occurs on cytosines in CG dinucleotides [24].”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“physical inactivity, the number of patients with T2D has dramatically increased worldwide [1].”
Research works printed but not linked: 1
- ISNH Sandovici, 2011, Dynamic epigenetic regulation by early-diet and aging of the type 2 diabetes susceptibility gene Hnf4a in pancreatic islets, Proc Natl Acad Sci U S A, 108, 5449
Cited by
Pidsley, R., Zotenko, E., Peters, T. J., Lawrence, M. G., Risbridger, G. P., Molloy, P., Van Djik, S., Muhlhausler, B., Stirzaker, C., & Clark, S. J. (2016) · Genome biology · doi:10.1186/s13059-016-1066-1 · Cited by 1,480
“Widespread aberrations in DNA methylation are a well-established hallmark of many cancers [1] and a growing body of literature shows a role for DNA methylation in the aetiology of other complex human diseases including chronic kidney disease [2], type 2 diabetes [3] and neuropsychiatric disease [4].”
Epigenetics in Human Obesity and Type 2 Diabetes
Ling, C., & Rönn, T. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.009 · Cited by 941
Self-citationJung, M., & Pfeifer, G. P. (2015) · BMC Biology · doi:10.1186/s12915-015-0118-4 · Cited by 535
“lead to perturbed glucagon and insulin secretion [62].”
Lawlor, N., George, J., Bolisetty, M., Kursawe, R., Sun, L., Sivakamasundari, V., Kycia, I., Robson, P., & Stitzel, M. L. (2017) · Genome Research · doi:10.1101/gr.212720.116 · Cited by 562
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
“Besides, the authors identified 1,649 CpG sites and 853 genes in T2D islets with changes in the DNA methylation level, including fat mass and obesity-associated (FTO), potassium voltage-gated channel subfamily Q member 1 (KCNQ1), and transcription factor-7-like-2 (TCF7L2).(148) One study investigated DNA methylation l…”
Fadista, J., Vikman, P., Laakso, E. O., Mollet, I. G., Esguerra, J. L., Taneera, J., Storm, P., Osmark, P., Ladenvall, C., Prasad, R. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402665111 · Cited by 483
“Genes found to be differentially methylated in human pancreatic islets of non-T2D versus T2D donors (49) were enriched to have allelic imbalance of expression in our dataset (Fisher exact test P value = 6.”
Self-citationβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
“Studies of pancreatic islets from nondiabetic donors (19,20) and patients with T2D (21) have identified epigenetic modifications in genes that potentially affect b-cell function.”
Self-citationDNA methylation in human diseases
Jin, Z., & Liu, Y. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.01.002 · Cited by 403
“A comparison of the methylation level of islets in patients with T2BM with those from normal donors showed that a series of sites had different DNA methylation levels which led to differential gene expression.(57) That included the decreased methylation of cyclin-dependent kinase inhibitor 1A and phosphodiesterase 7B…”
Nilsson, E., Jansson, P. A., Perfilyev, A., Volkov, P., Pedersen, M., Svensson, M. K., Poulsen, P., Ribel-Madsen, R., Pedersen, N. L., Almgren, P., et al. (2014) · Diabetes · doi:10.2337/db13-1459 · Cited by 391
Self-citationDNA methylation signatures in peripheral blood strongly predict all-cause mortality
Zhang, Y., Wilson, R., Heiss, J., Breitling, L. P., Saum, K.-U., Schöttker, B., Holleczek, B., Waldenberger, M., Peters, A., & Brenner, H. (2017) · Nature Communications · doi:10.1038/ncomms14617 · Cited by 382
Vienberg, S., Geiger, J., Madsen, S., & Dalgaard, L. T. (2017) · Acta Physiologica · doi:10.1111/apha.12681 · Cited by 373
“Furthermore, impaired insulin-stimulated muscle glucose disposal is the primary defect in the insulin resistant state during a hyperinsulinaemic–euglycaemic clamp (DeFronzo et al. 1985), highlighting the importance of skeletal muscle in glucose homoeostasis.”
Making sense of the ageing methylome
Seale, K., Horvath, S., Teschendorff, A., Eynon, N., & Voisin, S. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00477-6 · Cited by 274
Ronn, T., Volkov, P., Gillberg, L., Kokosar, M., Perfilyev, A., Jacobsen, A. L., Jorgensen, S. W., Brons, C., Jansson, P.-A., Eriksson, K.-F., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv124 · Cited by 270
Self-citationPrecision nutrition for prevention and management of type 2 diabetes
Wang, D. D., & Hu, F. B. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30037-8 · Cited by 267
Epigenetic modification of nucleic acids: from basic studies to medical applications
Chen, Y., Hong, T., Wang, S., Mo, J., Tian, T., & Zhou, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00599c · Cited by 263
Epigenetics of Aging and Aging-Associated Diseases
Saul, D., & Kosinsky, R. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010401 · Cited by 230
Bacos, K., Gillberg, L., Volkov, P., Olsson, A. H., Hansen, T., Pedersen, O., Gjesing, A. P., Eiberg, H., Tuomi, T., Almgren, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms11089 · Cited by 236
Self-citationRecent developments on the role of epigenetics in obesity and metabolic disease
van Dijk, S. J., Tellam, R. L., Morrison, J. L., Muhlhausler, B. S., & Molloy, P. L. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0101-5 · Cited by 233
“obesity and T2DM risk loci and DMRs associated with obesity and T2DM [43, 48, 62].”
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“Studies of pancreatic islets from non-diabetic donors (19, 20) and from patients with T2D (21) have identified epigenetic modifications in genes that potentially affect β-cell function.”
Self-citationMethylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks
Raghubeer, S., & Matsha, T. E. (2021) · Nutrients · doi:10.3390/nu13124562 · Cited by 214
Recent progress in genetic and epigenetic research on type 2 diabetes
Kwak, S. H., & Park, K. S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.7 · Cited by 223
The role of diet and exercise in the transgenerational epigenetic landscape of T2DM
Barrès, R., & Zierath, J. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.87 · Cited by 198
Dayeh, T., Tuomi, T., Almgren, P., Perfilyev, A., Jansson, P.-A., de Mello, V. D., Pihlajamäki, J., Vaag, A., Groop, L., Nilsson, E., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1178418 · Cited by 194
“Pyrosequencing was used to analyze DNA methylation of 5 different CpG sites in ABCG1, PHOSPHO1, SOCS3, SREBF1, and TXNIP in blood DNA from the Botnia subjects as previously described.(14) Primer sequences used for pyrosequencing are included in Supplementary Table 1.”
InfluentialSelf-citationNilsson, E., Matte, A., Perfilyev, A., de Mello, V. D., Käkelä, P., Pihlajamäki, J., & Ling, C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3204 · Cited by 191
“served a similar pattern in pancreatic islets, in which 97% of differentially methylated CpG sites showed decreased DNA methylation in diabetic compared with nondiabetic islets (2).”
Self-citationDNA methylation in the pathogenesis of type 2 diabetes in humans
Davegårdh, C., García-Calzón, S., Bacos, K., & Ling, C. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.022 · Cited by 197
“The 450k array was subsequently used to analyze DNA methylation in islets from 15 T2D and 34 non-diabetic donors [15] and identified significant methylation differences in 853 genes.”
Self-citationOxidative stress-mediated beta cell death and dysfunction as a target for diabetes management
Dinić, S., Arambašić Jovanović, J., Uskoković, A., Mihailović, M., Grdović, N., Tolić, A., Rajić, J., Đorđević, M., & Vidaković, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1006376 · Cited by 165
Metabolic memory: mechanisms and diseases
Dong, H., Sun, Y., Nie, L., Cui, A., Zhao, P., Leung, W. K., & Wang, Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01755-x · Cited by 214
Olsson, A. H., Volkov, P., Bacos, K., Dayeh, T., Hall, E., Nilsson, E. A., Ladenvall, C., Rönn, T., & Ling, C. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004735 · Cited by 174
“These results confirm previous efforts from our group and others [12,72,91,114].”
InfluentialSelf-citationGonzález, N., Diabetes Cancer Connect Consortium, Prieto, I., del Puerto-Nevado, L., Portal-Nuñez, S., Ardura, J. A., Corton, M., Fernández-Fernández, B., Aguilera, O., Gomez-Guerrero, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14472 · Cited by 168
“In this regard, SEPT9 is differentially methylated in human T2DM islet cells and was shown to perturb insulin and glucagon secretion [145].”
DNA methylation directs functional maturation of pancreatic β cells
Dhawan, S., Tschen, S.-I., Zeng, C., Guo, T., Hebrok, M., Matveyenko, A., & Bhushan, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79956 · Cited by 164
Volkov, P., Bacos, K., Ofori, J. K., Esguerra, J. L. S., Eliasson, L., Rönn, T., & Ling, C. (2017) · Diabetes · doi:10.2337/db16-0996 · Cited by 163
“4I), which is in line with what is seen in donors with diabetes (2).”
InfluentialSelf-citationSen, A., Heredia, N., Senut, M.-C., Land, S., Hollocher, K., Lu, X., Dereski, M. O., & Ruden, D. M. (2015) · Scientific Reports · doi:10.1038/srep14466 · Cited by 162
Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives
Berezin, A. (2016) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.03.016 · Cited by 159
Walaszczyk, E., Luijten, M., Spijkerman, A. M. W., Bonder, M. J., Lutgers, H. L., Snieder, H., Wolffenbuttel, B. H. R., & van Vliet-Ostaptchouk, J. V. (2018) · Diabetologia · doi:10.1007/s00125-017-4497-7 · Cited by 162
“These studies were conducted in a limited number of individuals (n = 16 to 87) [27, 28] and no overlap in identified CpGs was found between the studies when considering specific multiple-testing corrections applied by the authors (FDR < 5% [12, 27]; p < 0.”
(2007) · doi:10.1139/h06-102 · Cited by 160
DNA methylation and its role in the pathogenesis of diabetes
Bansal, A., & Pinney, S. E. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12521 · Cited by 171
“and Exoc3l2, had significant changes in mRNA expression as measured by microarray.(83) Increased DNA methylation at the promoter of Cdkn1a and Pde7b was associated with decreased transcriptional activity in clonal β-cells in vitro as well as impaired glucose stimulated insulin secretion.”
InfluentialDiabetic keratopathy: Insights and challenges
Priyadarsini, S., Whelchel, A. E., Nicholas, S. E., Sharif, R., Riaz, K. M., & Karamichos, D. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.02.005 · Cited by 164
Rfx6 Maintains the Functional Identity of Adult Pancreatic β Cells
Piccand, J., Strasser, P., Hodson, D. J., Meunier, A., Ye, T., Keime, C., Birling, M.-C., Rutter, G. A., & Gradwohl, G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.033 · Cited by 158
“Likewise, DNA methylation is reported also to be involved in the repression of some (e.g., Acot7) (Dayeh et al., 2014), but not other (Slc16a1/MCT1) (Pullen et al., 2011), members of this family.”
The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes
Sharma, M., Li, Y., Stoll, M. L., & Tollefsbol, T. O. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01329 · Cited by 152
DNA Modifications: Function and Applications in Normal and Disease States
Liyanage, V., Jarmasz, J., Murugeshan, N., Del Bigio, M., Rastegar, M., & Davie, J. (2014) · Biology · doi:10.3390/biology3040670 · Cited by 150
“and colleagues used the Illumina Infinium HumanMethylation450 BeadChip [277].”
Florath, I., Butterbach, K., Heiss, J. A., Bewerunge‐Hudler, M., Zhang, Y., Schöttker, B., & Brenner, H. (2015) · Diabetologia · doi:10.1007/s00125-015-3773-7 · Cited by 166
“In adipose tissue of 96 nondiabetic men, HbA1c level correlated significantly with DNAm at 711 CpG sites after correction for multiple testing (FDR of 5%), but in the female validation cohort (consisting of 94 nondiabetic women) these finding were not replicated [9].”
InfluentialType 2 diabetes: genetic data sharing to advance complex disease research
Flannick, J. A., & Florez, J. C. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.56 · Cited by 173
Epigenetic associations of type 2 diabetes and BMI in an Arab population
Al‐Muftah, W., Al-Shafai, M. N., Zaghlool, S. B., Visconti, A., Tsai, P.-C., Kumar, P., Spector, T. D., Bell, J. T., Falchi, M., & Suhre, K. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0177-6 · Cited by 158
“Only a small number of EWASs have been published so far on T2D [6, 7, 12, 14, 26, 52, 56] and on obesity or BMI ([1, 2, 15, 16, 18]; Sun.”
Hall, E., Volkov, P., Dayeh, T., Bacos, K., Rönn, T., Nitert, M. D., & Ling, C. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-103 · Cited by 141
“The data for three of these genes (that is, CDKN1A, IL1RL2, TNFRSF10B) have been reported previously [48] and are hence not reported here.”
Self-citationEpigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
Kokosar, M., Benrick, A., Perfilyev, A., Fornes, R., Nilsson, E., Maliqueo, M., Behre, C. J., Sazonova, A., Ohlsson, C., Ling, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22883 · Cited by 137
“Hirsutism 0 75% (54) NA Acne (yes/no) 0 64% (46) NA Hormones Estradiol (pg/ml) 38.”
Self-citationGenome-wide quantification of the effects of DNA methylation on human gene regulation
Lea, A. J., Vockley, C. M., Johnston, R. A., Del Carpio, C. A., Barreiro, L. B., Reddy, T. E., & Tung, J. (2018) · eLife · doi:10.7554/elife.37513 · Cited by 134
“, 2013), type II diabetes (Dayeh et al., 2014), and Alzheimer’s disease (Bakulskia et al.”
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Ling, C., Bacos, K., & Rönn, T. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00671-w · Cited by 161
Self-citationModulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes
Huda, M. N., Kim, M., & Bennett, B. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632335 · Cited by 142
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
Ahmed, S. A. H., Ansari, S. A., Mensah‐Brown, E. P. K., & Emerald, B. S. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00896-4 · Cited by 146
Thurner, M., van de Bunt, M., Torres, J. M., Mahajan, A., Nylander, V., Bennett, A. J., Gaulton, K. J., Barrett, A., Burrows, C., Bell, C. G., et al. (2018) · eLife · doi:10.7554/elife.31977 · Cited by 127
Dnmt3a is an epigenetic mediator of adipose insulin resistance
You, D., Nilsson, E., Tenen, D. E., Lyubetskaya, A., Lo, J. C., Jiang, R., Deng, J., Dawes, B. A., Vaag, A. A., Ling, C., et al. (2017) · eLife · doi:10.7554/elife.30766 · Cited by 133
“…recent genome-wide profiling studies have identified distinct global DNA methylation patterns that associate with obesity and diabetes in humans (Dayeh et al., 2014; Feinberg et al., 2010; Kirchner et al., 2016; Multhaup et al., 2015; Nilsson et al., 2015; Volkmar et al., 2012; Volkov et al.,…”
Self-citationVolkov, P., Olsson, A. H., Gillberg, L., Jørgensen, S. W., Brøns, C., Eriksson, K.-F., Groop, L., Jansson, P.-A., Nilsson, E., Rönn, T., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157776 · Cited by 123
Self-citationEpigenetic Mechanisms of Aging and Aging-Associated Diseases
la Torre, A., Vecchio, F. L., & Greco, A. (2023) · Cells · doi:10.3390/cells12081163 · Cited by 150
Allum, F., Shao, X., Guénard, F., Simon, M.-M., Busche, S., Caron, M., Lambourne, J., Lessard, J., Tandre, K., Hedman, Å. K., et al. (2015) · Nature Communications · doi:10.1038/ncomms8211 · Cited by 115
“Other investigated features of DNA methylation variation in human populations include the effects of environmental 4 and genetic factors 3,5 and the role of methylation in complex disease susceptibility 6-8 .”
Epigenetic reprogramming in metabolic disorders: nutritional factors and beyond
Cheng, Z., Zheng, L., & Almeida, F. A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.004 · Cited by 112
“glucagon and insulin secretion, glucose homeostasis [21]”
Milk’s Role as an Epigenetic Regulator in Health and Disease
Melnik, B. C., & Schmitz, G. (2017) · Diseases · doi:10.3390/diseases5010012 · Cited by 118
“In fact, decreased FTO methylation has been demonstrated in pancreatic islets of T2DM patients compared to non-diabetic controls [155].”
Multhaup, M. L., Seldin, M. M., Jaffe, A. E., Lei, X., Kirchner, H., Mondal, P., Li, Y., Rodriguez, V., Drong, A., Hussain, M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.014 · Cited by 111
“We performed a similar mouse-human comparison in pancreatic islets using published DNAmdata from T2D and control subjects (Dayeh et al., 2014), showing that 67% (odds ratio = 7.2, p = 7.2 3 10 6) of the mouse pancreatic islet DMRs that replicated in the human data had methylation change in the same…”
InfluentialEpigenetic regulation of insulin action and secretion – role in the pathogenesis of type 2 diabetes
Ling, C. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13049 · Cited by 122
Self-citationDNA Methylation as a Diagnostic and Therapeutic Target in the Battle Against Type 2 Diabetes
Rönn, T., & Ling, C. (2015) · Epigenomics · doi:10.2217/epi.15.7 · Cited by 114
Self-citationLea, A. J., Tung, J., & Zhou, X. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005650 · Cited by 117
“In humans, DNA methylation levels are strongly linked to disease, including major public health burdens such as diabetes [7,8], Alzheimer’s disease [9,10], and many forms of cancer [7,11–15].”
Dahlman, I. A., Sinha, I., Gao, H., Brodin, D., Thorell, A., Rydén, M., Andersson, D. P., Henriksson, J., Perfilyev, A., Ling, C., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.31 · Cited by 107
Self-citationKhan, S., & Jena, G. (2015) · Epigenomics · doi:10.2217/epi.15.20 · Cited by 102
Genome-Wide DNA Methylation Profiles Indicate CD8+ T Cell Hypermethylation in Multiple Sclerosis
Bos, S. D., Page, C. M., Andreassen, B. K., Elboudwarej, E., Gustavsen, M. W., Briggs, F. B. S., Quach, H., Leikfoss, I. S., Bjølgerud, A., Berge, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117403 · Cited by 105
“CpG-sites with the lowest nominal p-values and at least 5% absolute difference in methylation [29] between MS patients and controls were examined.”
Peiris, H., Duffield, M. D., Fadista, J., Jessup, C. F., Kashmir, V., Genders, A. J., McGee, S. L., Martin, A. M., Saiedi, M., Morton, N., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006033 · Cited by 94
“…islet data demonstrated that mouse islet RCAN1 expression is correlated with increased plasma triglycerides To understand more about RCAN1 in human T2D islets, we analysed previously published data using the Infinium 450k array to examine global changes in DNA methylation in human T2D islets [18].”
InfluentialSelf-citationMeeks, K. A. C., Henneman, P., Venema, A., Addo, J., Bahendeka, S., Burr, T., Danquah, I., Galbete, C., Mannens, M. M. A. M., Mockenhaupt, F. P., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy171 · Cited by 117
Hall, E., Dekker Nitert, M., Volkov, P., Malmgren, S., Mulder, H., Bacos, K., & Ling, C. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.11.019 · Cited by 97
Self-citationBerge, L. I., & Riise, T. (2015) · International Journal of Endocrinology · doi:10.1155/2015/164760 · Cited by 93
Côté, S., Gagné-Ouellet, V., Guay, S.-P., Allard, C., Houde, A.-A., Perron, P., Baillargeon, J.-P., Gaudet, D., Guérin, R., Brisson, D., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0239-9 · Cited by 94
“recently reported in an EWAS that PRDM16 gene DNA methylation was decreased in human pancreatic islets from patients with T2D [52].”
InfluentialCrujeiras, A. B., Díaz‐Lagares, Á., Moreno‐Navarrete, J. M., Sandoval, J., Hervás, D., Gómez, A., Ricart, W., Casanueva, F. F., Esteller, M., & Fernández‐Real, J. M. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.002 · Cited by 95
“Moreover, the methylome of human pancreatic islets associated with type 2 diabetes (T2D) has been characterized, demonstrating that altered DNA methylation in human islets contributes to perturbed hormone secretion and the pathogenesis of T2D.(14) Furthermore, DNA methylation levels in adipose tissue have been related…”
InfluentialImpact of fetal and neonatal environment on beta cell function and development of diabetes
Nielsen, J. H., Haase, T. N., Jaksch, C., Nalla, A., Søstrup, B., Nalla, A. A., Larsen, L., Rasmussen, M., Dalgaard, L. T., Gaarn, L. W., et al. (2014) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12504 · Cited by 103
“Genome-wide DNA methylation analysis of human islets from T2M and nondiabetic donors has identified a number of candidate genes that influence insulin secretion (142).”
Díaz, M., García-Beltrán, C., Sebastiani, G., de Zegher, F., López‐Bermejo, A., & Ibáñez, L. (2016) · Diabetes · doi:10.2337/db16-0776 · Cited by 98
“of adjustment for cell composition in placenta/cord blood (24), the influence of maternal genetics on placental gene expression, the potential underrepresentation of differential methylation in CpG islands (25), and the inability to obtain—for ethical reasons—target tissues for the assessment of tissue-specific DNA me…”
Differential methylation of genes in individuals exposed to maternal diabetes in utero
Chen, P., Piaggi, P., Traurig, M. T., Bogardus, C., Knowler, W. C., Baier, L. J., & Hanson, R. L. (2017) · Diabetologia · doi:10.1007/s00125-016-4203-1 · Cited by 92
Chen, G., Chen, H., Ren, S., Xia, M., Zhu, J., Liu, Y., Zhang, L., Tang, L., Sun, L., Liu, H., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.020 · Cited by 92
Genetics of metabolic syndrome
Stančáková, A., & Laakso, M. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9293-9 · Cited by 100
“Epigenetic studies of type 2 diabetes have found differential methylation between diabetes cases and controls in a number of genetic loci, including IRS1 and FTO [76–78].”
Epigenetics in diabetic nephropathy, immunity and metabolism
Keating, S. T., van Diepen, J. A., Riksen, N. P., & El-Osta, A. (2018) · Diabetologia · doi:10.1007/s00125-017-4490-1 · Cited by 82
Daneshpajooh, M., Bacos, K., Bysani, M., Bagge, A., Ottosson-Laakso, E., Vikman, P. J., Eliasson, L., Mulder, H., & Ling, C. (2016) · Diabetologia · doi:10.1007/s00125-016-4113-2 · Cited by 84
“We recently reported decreased DNA methylation and increased gene expression of HDAC7 in pancreatic islets from human donors with type 2 diabetes [3].”
InfluentialSelf-citationGene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate
Ortega, Á., Berná, G., Rojas, A., Martín, F., & Soria, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061188 · Cited by 96
“Finally, decreased methylation of the septin 9 (SEPT9) gene has been identified in an experimental study using pancreatic islets of patients with T2DM [273].”
Yuan, L., Guo, L., Yuan, C., Zhang, Y., Han, K., Nandi, A. K., Honig, B. H., & Huang, D.-S. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2866836 · Cited by 82
“In addition, DNAmethylation sites are often located in core sequences of gene promoters and transcription start sites (TSS) [35], and they often affect the nearest gene [36].”
Bysani, M., Agren, R., Davegårdh, C., Volkov, P., Rönn, T., Unneberg, P., Bacos, K., & Ling, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-44076-8 · Cited by 80
Self-citationMilk: an epigenetic amplifier of FTO-mediated transcription? Implications for Western diseases
Melnik, B. C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0746-z · Cited by 85
Rönn, T., Ofori, J. K., Perfilyev, A., Hamilton, A., Pircs, K., Eichelmann, F., García-Calzón, S., Karagiannopoulos, A., Stenlund, H. C., Wendt, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43719-9 · Cited by 88
Self-citationPleiotropic and Adverse Effects of Statins—Do Epigenetics Play a Role?
Bridgeman, S. C., & Mamotte, C. D. S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242081 · Cited by 89
“Epigenetic changes also occur due to aging, and these changes have been associatedwith disorders such as T2D (Bacos et al., 2016).”
InfluentialGarcía-Calzón, S., Perfilyev, A., Männistö, V., de Mello, V. D., Nilsson, E., Pihlajamäki, J., & Ling, C. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0400-0 · Cited by 79
“Genomic DNA was extracted from cells using DNeasy blood and tissue kit (Qiagen), and DNA methylation was analyzed using PyroSequencing as previously reported [18].”
Self-citationEpigenetics of chronic inflammatory diseases
Stylianou, E. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s129027 · Cited by 79
“In human pancreatic isletsfrom T2DM patients differentially methylated sites are associated with altered expression of genes involved in dysregulated glucagon and insulin secretion.(55) Fascinating evidence from a study comparing prediabetic, nondiabetic, and T2DM patients indicates that DNA methylation varies accordi…”
Role of non‐coding RNA s in pancreatic beta‐cell development and physiology
Eliasson, L., & Esguerra, J. L. S. (2014) · Acta Physiologica · doi:10.1111/apha.12285 · Cited by 82
“Indeed, epigenetic changes in T2D human islets were recently demonstrated to be associated with reduced expression of the exocytotic gene EXOC3L2 (Dayeh et al. 2014).”
Self-citationLawlor, N. T., Márquez, E. J., Orchard, P., Narisu, N., Shamim, M. S., Thibodeau, A., Varshney, A., Kursawe, R., Erdos, M. R., Kanke, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.083 · Cited by 78
Multi-omics profiling: the way toward precision medicine in metabolic diseases
Hu, C., & Jia, W. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab051 · Cited by 117
“…HHEX, IRS1, KCNQ1, PPARG, TCF7L2, GLP1R Pancreatic islets DNA methylation Ling et al. (2008); Yang et al. (2011, 2012); Hall et al. (2013); Dayeh et al. (2014) MALT1 Whole blood DNA methylation Yuan et al. (2014) PPARG, KCNQ1, TCF7L2, IRS1 Adipose tissue DNA methylation Nilsson et al.…”
Differential DNA methylation identified in the blood and retina of AMD patients
Oliver, V. F., Jaffe, A. E., Song, J., Wang, G., Zhang, P., Branham, K. E. H., Swaroop, A., Eberhart, C. G., Zack, D. J., Qian, J. X., et al. (2015) · Epigenetics · doi:10.1080/15592294.2015.1060388 · Cited by 80
“Likewise, relatively small methylation differences have be linked to changes in gene expression, which hint at potential functional effects of our observed methylation differences.(16) This is one of the first studies to show a relationship between DNAm and AMD,(38-40) but many questions remain.”
Arachidonic and oleic acid exert distinct effects on the DNA methylome
Silva-Martínez, G. A., Rodríguez‐Ríos, D., Alvarado‐Caudillo, Y., Vaquero, A., Esteller, M., Carmona, F. J., Morán, S., Nielsen, F. C., Lindholm, M., Wróbel, K., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1161873 · Cited by 79
Synthetic epigenetics—towards intelligent control of epigenetic states and cell identity
Jurkowski, T. P., Ravichandran, M., & Stepper, P. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0044-x · Cited by 81
“Chronic diseases are very often correlated with abnormal epigenetic changes [45-48].”
DNA methylation and type 2 diabetes: a systematic review
Nadiger, N., Veed, J. K., Nataraj, P. C., & Mukhopadhyay, A. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01670-6 · Cited by 85
“…[53] which is known to be involved in energy and insulin signaling pathways [54], PTBP1 [36] that is involved in nucleic acid binding, and ANO8 [28] that is involved in calcium transport, were hypermethylated in diabetic twins in peripheral blood, adipose tissue and pancreatic islets,…”
InfluentialStančáková, A., & Laakso, M. (2016) · Endocrine development · doi:10.1159/000439418 · Cited by 82
Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 78
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
“DNA methylation DNA methylation has been found to be altered in pancreatic islets from human donors with type 2 diabetes and associated with impaired insulin secretion (251-253).”
Park, L. K., Maione, A. G., Smith, A., Gerami‐Naini, B., Iyer, L. K., Mooney, D. J., Veves, A., & Garlick, J. A. (2014) · Epigenetics · doi:10.4161/15592294.2014.967584 · Cited by 76
Muka, T., Nano, J., Voortman, T., Braun, K. V. E., Ligthart, S., Stranges, S., Bramer, W. M., Troup, J., Chowdhury, R., Dehghan, A., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.04.002 · Cited by 81
Papuc, C. P., GORAN, G. V., Predescu, N. C., Tudoreanu, L., & Ștefan, G. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1815644 · Cited by 77
García-Calzón, S., Perfilyev, A., de Mello, V. D., Pihlajamäki, J., & Ling, C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00423 · Cited by 78
Self-citationPancreatic α-cells – The unsung heroes in islet function
Wendt, A., & Eliasson, L. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.01.006 · Cited by 87
Self-citationNilsson, E., & Ling, C. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0399-2 · Cited by 71
“date genes that affect insulin secretion from pancreatic beta cells and thereby could play an important role in the pathogenesis of type 2 diabetes [8, 14].”
Self-citation
Metadata
- Authors
- Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., Bacos, K., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-06
- Volume
- 10
- Issue
- 3
- Pages
- e1004160
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3945174
- OpenAlex
- W2132464305
- Cited by
- 523
- References
- 90
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 37 · 2021: 47 · 2020: 30 · 2019: 41 · 2018: 43 · 2017: 47 · 2016: 50 · 2015: 49 · 2014: 34
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- DNA methylation, pancreatic islets, type 2 diabetes, insulin secretion, glucagon secretion, pancreatic beta cells, alpha cells, epigenetics, differentially methylated genes, p21, PDE7B, SEPT9, TCF7L2, FTO, KCNQ1, promoter methylation, exocytosis, methylome
- MeSH terms
- Insulin Secretion, Diabetes Mellitus, Type 2, Disease Susceptibility, Exocytosis, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, Genome, Human, CpG Islands, DNA Methylation, Epigenesis, Genetic, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.